Correlation Between BioLife Sciences and Bionano Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLife Sciences and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLife Sciences and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLife Sciences and Bionano Genomics, you can compare the effects of market volatilities on BioLife Sciences and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLife Sciences with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLife Sciences and Bionano Genomics.

Diversification Opportunities for BioLife Sciences and Bionano Genomics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioLife and Bionano is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioLife Sciences and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and BioLife Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLife Sciences are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of BioLife Sciences i.e., BioLife Sciences and Bionano Genomics go up and down completely randomly.

Pair Corralation between BioLife Sciences and Bionano Genomics

Given the investment horizon of 90 days BioLife Sciences is expected to generate 16.41 times more return on investment than Bionano Genomics. However, BioLife Sciences is 16.41 times more volatile than Bionano Genomics. It trades about 0.12 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.14 per unit of risk. If you would invest  0.04  in BioLife Sciences on November 27, 2024 and sell it today you would lose (0.03) from holding BioLife Sciences or give up 75.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioLife Sciences  vs.  Bionano Genomics

 Performance 
       Timeline  
BioLife Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Bionano Genomics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

BioLife Sciences and Bionano Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLife Sciences and Bionano Genomics

The main advantage of trading using opposite BioLife Sciences and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLife Sciences position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.
The idea behind BioLife Sciences and Bionano Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements